Phase II Study of Gemcitabine, Carboplatin, and Bevacizumab in Patients With Advanced Unresectable or Metastatic Urothelial Cancer

PURPOSE: Although gemcitabine and carboplatin (GCa) is a standard option for patients with advanced urothelial cancer (UC) who are ineligible for cisplatin, outcomes remain poor. This trial evaluated the efficacy and safety of bevacizumab with GCa in advanced UC. PATIENTS AND METHODS: Patients with...

Full description

Saved in:
Bibliographic Details
Main Authors: Balar, Arjun V., Apolo, Andrea B., Ostrovnaya, Irina, Mironov, Svetlana, Iasonos, Alexia, Trout, Alisa, Regazzi, Ashley M., Garcia-Grossman, Ilana R., Gallagher, David J., Milowsky, Matthew I., Bajorin, Dean F.
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2013
Subjects:
Original Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3574268/
https://ncbi.nlm.nih.gov/pubmed/23341513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.42.5215
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items